Gilead Sciences, Inc. is a research-based biopharmaceutical company founded in 1987. Together we deliver life-saving therapies to patients in need. With the commitment and drive you bring to the workplace every day, you will be part of a team that is changing the world and helping millions of people live healthier, more fulfilling lives. Our worldwide staff is a close community where you can see the tangible results of your contributions, where every individual matters, and everyone has a chance to enhance their skills through ongoing development. Our scientific focus has resulted in marketed products that are benefiting hundreds of thousands of people, a pipeline of late-stage drug candidates, and unmatched patient access programs to ensure medications are available to those who could otherwise not afford them. By joining Gilead, you will further our mission to address unmet medical needs and improve life by advancing the care of patients with life-threatening diseases.
Specific Responsibilities:
Serve as Subject Matter Expert on reliability aspects of aseptic fill/finish equipment
Collaborate closely with equipment engineers, manufacturing personnel, technical services scientists, validation engineers, automation engineers and quality staff to identify and resolve potential production risks associated with operation of GxP equipment.
Work in a matrix environment as a technical lead to achieve operational excellence on fill/finish processes.
Identify process and equipment risks by enhanced FMEA tools.
Serve as a key member of technology transfer team to identify and address any production equipment gaps.
Proactively assess production plans on new filling lines and identify and mitigate potential risks by leading engineering studies.
Be able to articulate complex manufacturing and technical issues to senior management.
Work with equipment suppliers to identify best-in-class operational and maintenance practices for pharmaceutical manufacturing equipment.
Knowledge & Skills
Deep expertise in sterile pharmaceutical fill/finish equipment including isolators, filling systems, robotics, freeze-dryers, and associated systems
Demonstrated skills in diagnosis of reliability issues, using new tools and existing failure-mode data.
Understanding of complex formulation requirements such as biologics, long-acting release formulations and colloidal systems is highly desired.
Expertise in modern sterile pharma equipment design, build, integration and operation.
Education & Experience
10+ years of relevant experience and a BS or related fields.
8+ years of relevant experience and a MA or MBA.
Has previous experience in engineering in highly regulated manufacturing environments.
Knowledge of the process engineering and reliability engineering principles.
Previous hands-on experience supporting and executing process development, engineering, and manufacturing projects involving complex manufacturing equipment.
Experience working with regulatory agencies (FDA and EMEA) for biologics or pharmaceuticals.
Knowledge of scientific and engineering principles in the biopharmaceutical industry.
Experience with manufacturing equipment that are integrated with site Process Control System (PCS).
Familiarity with robotics, isolators and aseptic filling systems.
Foster City, CA
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company’s products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases.
It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of HIV/AIDS and liver diseases, hematology/oncology, inflammation/respiratory diseases, and others.
The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Scholar Rock Holding Corporation; Tango Therapeutics; National Cancer Institute; Pfizer, Inc.; Sangamo Therapeutics, Inc.; Gadeta B.V.; HiFiBiO Therapeutics; Agenus Inc.; HOOKIPA Pharma Inc.; Goldfinch Bio, Inc.; and insitro Inc. The company was founded in 1987 and is headquartered in Foster City, California.